dalteparin has been researched along with Lung Injury, Acute in 2 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kerr, NA | 2 |
| de Rivero Vaccari, JP | 2 |
| Weaver, C | 1 |
| Dietrich, WD | 2 |
| Ahmed, T | 1 |
| Keane, RW | 2 |
| Abbassi, S | 1 |
| Kaur, H | 1 |
| Zambrano, R | 1 |
| Wu, S | 1 |
2 other studies available for dalteparin and Lung Injury, Acute
| Article | Year |
|---|---|
Enoxaparin Attenuates Acute Lung Injury and Inflammasome Activation after Traumatic Brain Injury.
Topics: Acute Lung Injury; Animals; Anticoagulants; Brain Injuries, Traumatic; Disease Models, Animal; Enoxa | 2021 |
Traumatic Brain Injury-Induced Acute Lung Injury: Evidence for Activation and Inhibition of a Neural-Respiratory-Inflammasome Axis.
Topics: Acute Lung Injury; Animals; Anticoagulants; Apoptosis Regulatory Proteins; Brain Injuries, Traumatic | 2018 |